KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹226 Cr | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr |
What is the latest Total Current Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹226 Cr |
| Mar2025 | ₹170 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹126 Cr |
| Mar2022 | ₹139 Cr |
How is Total Current Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹226 Cr | 33.05 | |
| Mar2025 | ₹170 Cr | 11.63 | |
| Mar2024 | ₹152 Cr | 20.57 | |
| Mar2023 | ₹126 Cr | -9.71 | |
| Mar2022 | ₹139 Cr | - | |
Compare Total Current Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,836.8 Cr | 5.1% | -0.6% | 292.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 5.1% |
-0.6% |
292.3% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses